| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |